Dr. Étienne Gaudette is a researcher specializing in health economics, economics of aging, microsimulation methods and applied macroeconomics. As a health economist, Dr. Gaudette is most interested about the power of structures and incentives to influence the decisions which, when aggregated, produce the demand for care. His research aims to understand the impact of the environment in which patients make decisions—with regard to available technologies, treatment options, health insurance, waiting times, etc.—on their choices and health, and the potential of changing this environment to improve patient outcomes. An important portion of his research targets large-picture versions of these aims. For instance, his work with the Future Elderly Model (FEM), a dynamic microsimulation that follows a representative sample of Americans aged 50 and older, studies policies to improve health at a national level. His work also involves collaborations with healthcare professionals to ensure the real-world impact of his work. In particular, he has been working with neurologists of the TRACK-TBI study group since 2016 to assess the impact of triage decisions and follow-up care for the economic wellbeing of patients after a traumatic brain injury. Dr. Gaudette’s research has been featured in renowned health economics journals such as PharmacoEconomics and Value in Health, as well as influent medical journals such as Medical Care and American Journal of Preventive Medicine.
After obtaining a Ph.D. in Economics from the Université du Québec à Montréal in 2013, Dr. Gaudette had a two-year tenure as a postdoctoral scholar at the Schaeffer Center of the USC Price School of Public Policy, ranked 3rd in the USA in Health Policy and Management by US News and World Report. From 2015 to 2017, he served as the Policy Director of the Roybal Center for Health Policy Simulation and a Research Assistant Professor at the department of Pharmaceutical and Health Economics at USC. He currently serves as a Senior Health Economist at the Ontario Ministry of Health and Long-Term Care, an Adjunct Research Professor at the University of Southern California (USC) Department of Pharmaceutical and Health Economics, and a Health Economist at the USC Keck-Schaeffer Initiative for Population Health Policy.